Cassella

Last updated
Cassella
Formerly
  • Cassel & Reiss (1798–1828)
  • Leopold Cassella & Co. (1828–1925)
  • Cassella Farbwerke Mainkur (1951–1978)
  • Cassella AG (1978–1995)
Industry Chemicals, pharmaceuticals, cosmetics
Founded1798
Founder Leopold Cassella
Defunct1995
Successor Sanofi
Headquarters,
Germany
Products Dyes, drugs, cosmetics, other chemical products
Parent Hoechst AG   OOjs UI icon edit-ltr-progressive.svg

Cassella AG, formerly Leopold Cassella & Co. and Cassella Farbwerke Mainkur AG, commonly known as Cassella, was a German chemical and pharmaceutical company with headquarters in Frankfurt am Main. Founded in 1798, in the Frankfurt Jewish Alley by Leopold Cassella, Cassella operated as an independent company until 1995, and was one of many predecessor companies of today's Sanofi. Its main products were dyes, drugs, cosmetics and various other chemical products. From 1949, Cassella focused increasingly on pharmaceuticals and cosmetics rather than its former primary focus, dyes. Much of its history is closely associated with the Gans family, a prominent family of industrialists and philanthropists and former owners of Cassella.

Contents

History

The firm's founder Leopold Cassella (1766-1847) Leopold Cassella.jpeg
The firm's founder Leopold Cassella (1766–1847)

The company was founded as a spice store inside the Frankfurt Jewish Alley in 1798 by the Jewish businessman Leopold Cassella and his brother-in-law Isaac Elias Reiss, and was originally named Cassel & Reiss. In its early years, the company focused on importing luxury goods from India, China and South America, and Cassel and Reiss also founded a sugar refinery in 1812.

The former headquarters of Cassella in Fechenheim, Frankfurt, with the iconic Cassella Erlenmeyer flask logo on the roof Cassella Hauptgebaude.JPG
The former headquarters of Cassella in Fechenheim, Frankfurt, with the iconic Cassella Erlenmeyer flask logo on the roof

Himself childless, Cassella accepted Ludwig Aaron Gans as a partner in 1828, and the company became known as Leopold Cassella & Co. Gans was married to Cassella's niece, and the Gans family rose to great prominence as industrialists and philanthropists in Frankfurt in the following century. The family converted from Judaism to Protestantism in the late 19th century, and several family members were ennobled. In the 19th century, Cassella primarily traded with dye. In 1870, Friedrich and Leo Gans founded a dye factory at Mainkur in Fechenheim with their brother-in-law Bernhard Weinberg and the chemist August Leonhardt, called Frankfurter Anilinfarbenfabrik von Gans und Leonhardt. In 1894, the dye factory was merged with the Leopold Cassella & Co. dye wholesale company.

Arthur Weinberg in his laboratory, 1895 Labor Arthur Weinbergs in der Cassella-Anilinfarbenfabrik.jpeg
Arthur Weinberg in his laboratory, 1895

The Cassella dye factory was the largest employer of Fechenheim, employing around 3,000 people by 1914, and was the world's largest producer of synthetic dyes by the turn of the century. In 1900, Arthur Weinberg established a pharmaceutical division of the company, and collaborated closely with his friend Paul Ehrlich, the founder of chemotherapy. In 1925, Cassella merged into the new IG Farben trust, with Cassella co-owners Leo Gans and Arthur von Weinberg joining its supervisory board. After World War II the company was reestablished as Cassella Farbwerke Mainkur AG and the rebuilding under Richard von Szilvinyi and Werner Zerweck's leadership proved very successful, making the company the "darling of the stock exchange" in the 1950s. [1] In 1951, Cassella had already surpassed its prewar production. Pharmaceutical research was reestablished in 1949 , and a new laboratory was built. [2] From 1949 the company focused increasingly on pharmaceuticals rather than its traditional primary focus, dyes. The company had around 2,000 employees by the early 1950s, and initially had the same shareholders as BASF, Bayer and Hoechst. In the mid 1950s BASF, Bayer and Hoechst bought the controlling majority with 25.1% each, while the remaining shares were owned by smaller shareholders. In 1970, Hoechst acquired the shares of BASF and Bayer. [3] The company name was changed to Cassella AG in 1978.

Cassella operated as a separate company until 1995, when it was integrated in Hoechst and the smaller Cassella shareholders bought out. The Cassella cosmetics department was discontinued and the Cassella cosmetics subsidiary Jade in Fechenheim was sold to L'Oréal. In 1999, Hoechst merged with Rhône-Poulenc to form the French-German company Aventis with headquarters in Strasbourg and the main research and production facilities in Frankfurt. In 2004, this company merged with Sanofi-Synthélabo to form Sanofi-Aventis, which was renamed Sanofi in 2011. Sanofi, headquartered in Paris, employs around 7,000 people in its Frankfurt office, which also includes Sanofi's largest research and development centre.

Cassella and its subsidiaries had around 2,800 employees as of 1993.

In 2012, AllessaChemie secured the trademark rights to Cassella and has been using the traditional brand logo again since December of that year as a neon sign on the roof of the Cassella building in Frankfurt-Fechenheim. The logo has a diameter of five meters and is equipped with 208 fluorescent tubes with a total length of 178 meters. Since October 1, 2012, the former AllessaChemie GmbH has been trading as Allessa GmbH. It has been part of the WeylChem group of companies since 2013.

Bibliography

Related Research Articles

<span class="mw-page-title-main">IG Farben</span> Former German chemicals conglomerate

I. G. Farbenindustrie AG, commonly known as IG Farben, was a German chemical and pharmaceutical conglomerate. Formed in 1925 from a merger of six chemical companies—BASF, Bayer, Hoechst, Agfa, Chemische Fabrik Griesheim-Elektron, and Chemische Fabrik vorm. Weiler Ter Meer—it was seized by the Allies after World War II and divided back into its constituent companies.

<span class="mw-page-title-main">Hoechst AG</span> German chemicals company

Hoechst AG was a German chemicals then life-sciences company that became Aventis Deutschland after its merger with France's Rhône-Poulenc S.A. in 1999. With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.

The American IG Chemical Corporation, or American IG, for short, was an American holding company incorporated under the Delaware General Corporation Law in April 1929 and headquartered in New York City. It had stakes in General Aniline Works (GAW), Agfa-Ansco Corporation, and Winthrop Chemical Company, among others, and was engaged in manufacture and sale of pharmaceuticals, photographic products, light weight metals, synthetic gasoline, synthetic rubber, dyes, fertilizers, and insecticides. The Moody's industrial manual listed an affiliation between IG Farben and American IG at the time of founding. First, Hermann Schmitz, who was the second after Carl Bosch in IG Farben's hierarchy, and then his brother Dietrich A. Schmitz served as American IG's presidents. It was re-incorporated as General Aniline & Film (GAF) Corp. in 1939 after a merge with General Aniline Works.

<span class="mw-page-title-main">Höchst (Frankfurt am Main)</span> Quarter of Frankfurt am Main in Hesse, Germany

Höchst is a quarter of Frankfurt am Main, Germany. It is part of the Ortsbezirk West.

<span class="mw-page-title-main">King Pharmaceuticals</span> American pharmaceutical company

King Pharmaceuticals, is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. On October 12, 2010, King was acquired by Pfizer for $14.25 per share. King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; St. Louis, Missouri; St. Petersburg, Florida; and Middleton, Wisconsin. They employed approximately 2,700 people including a sales force of over 1,000 individuals.

<span class="mw-page-title-main">Roussel Uclaf</span> French pharmaceutical company

Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi.

<span class="mw-page-title-main">Clariant</span>

Clariant AG is a Swiss multinational speciality chemicals company, formed in 1995 as a spin-off from Sandoz. The company is focused on four business areas: care chemicals ; catalysis; natural resources ; and plastics & coatings. Headquartered in Muttenz, Switzerland, the public company encompasses 110 operating companies in 53 countries. Major manufacturing sites are located in Europe, North America, South America, China, and India. In 2015, sales from continuing operations were 5.8 billion CHF.

Rhône-Poulenc was a French chemical and pharmaceutical company founded in 1928. In 1999 it merged with Hoechst AG to form Aventis. As of 2015, the pharmaceutical operations of Rhône-Poulenc are part of Sanofi and the chemicals divisions are part of Solvay group and Bayer Crop Science.

Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.

May & Baker was a British chemical company founded by John May and William Gerrard Baker in Wandsworth, London in 1839. They initially specialized in the manufacture of chemicals derived from mercury and bismuth. Over the years they diversified into other chemical fields including photographic chemicals, pharmaceuticals, agrochemicals, and chemicals for research and development.

<span class="mw-page-title-main">Eugen de Haën</span> German chemist and entrepreneur

Carl Johann Eugen de Haën, often known as Eugen de Haën or Eugen de Haen, was a German chemist and entrepreneur. He was founder of the chemistry factory E. de Haën & Co.

Hoechst Schering AgrEvo GmbH was a Düsseldorf-based limited liability company owned by Hoechst AG and Schering AG that only existed as an independent company for five years, from 1994 to 1999.

<span class="mw-page-title-main">Leopold Cassella</span>

Leopold Cassella was a German businessman, known for having founded the company Cassella, one of many predecessor companies of today's Sanofi.

Adolf Stachel was a German chemist, researcher and inventor, who worked as a researcher at the chemical and pharmaceutical company Cassella in Frankfurt-Fechenheim for much of his career.

<span class="mw-page-title-main">Gans family</span>

The Gans family is a prominent German family of industrialists and philanthropists from Frankfurt am Main. It is descended from Ludwig Aaron Gans, a Jewish businessman from Celle, who became an apprentice in the firm Caßel & Reiß in Frankfurt in 1814. In 1828, he married Rosette Goldschmidt (1805–1868), a niece and adopted daughter of the firm's owner Leopold Cassella, and was accepted as a partner of the firm. In 1848, Gans became sole owner of Leopold Cassella & Co., as the company was then named. Ludwig Aaron Gans was the father of the major industrialist Friedrich Ludwig von Gans, who was ennobled in 1912, and of the chemist and industrialist Leo Gans. The family converted from Judaism to Protestantism in the late 19th century.

<span class="mw-page-title-main">Ludwig Aaron Gans</span> German entrepreneur

Ludwig Aaron Gans was a German industrialist and owner of the company Cassella.

Werner Zerweck was a German chemist, inventor and industrial leader, who served as CEO of the chemical and pharmaceutical company Cassella from 1953 to 1963. Under his leadership the company focused increasingly on pharmaceuticals and cosmetics rather than its former primary focus, dyes. He was also a member of the advisory board of Deutsche Bank from 1953. Zerweck was one of the pioneers in the development of synthetic fibers.

<span class="mw-page-title-main">Carl von Weinberg</span> German chemist and art collector

Carl von Weinberg was an important Jewish German chemist, entrepreneur, patron of the arts and philanthropist.

References

  1. Werner Abelshauser, Die BASF: eine Unternehmensgeschichte, p. 464, C.H.Beck, 2002
  2. http://rzbl04.biblio.etc.tu-bs.de/dfg-files/00040488/dwl/00000146.pdf Archived 2015-05-18 at the Wayback Machine Cassella Farbwerke Mainkur begründet
  3. Fred Aftalion (1991). A history of the international chemical industry. trans. Otto Theodor Benfey. University of Pennsylvania Press. p. 247. ISBN   978-0-8122-8207-8.